Phase 1 Single and Multiple Dose Study of FPA008 in Healthy Volunteers and Rheumatoid Arthritis Subjects

NCT01962337 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

66

Enrollment

INDUSTRY

Sponsor class

Stopped We have discontinued development of FPA008 in RA

Conditions

Healthy
Rheumatoid Arthritis

Interventions

DRUG: FPA008
DRUG: Placebo

Sponsor

Five Prime Therapeutics, Inc.